99% Savings - Buy Just @1 Rs X
Rabemek DSR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Rabemek DSR safe for pregnant women?
Rabemek DSR may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Rabemek DSR again without your doctor's advice.
Is the use of Rabemek DSR safe during breastfeeding?
Rabemek DSR can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Rabemek DSR on the Kidneys?
Kidney can be affected by Rabemek DSR. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Rabemek DSR on the Liver?
The liver can be affected by Rabemek DSR. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Rabemek DSR only after medical advice.
What is the effect of Rabemek DSR on the Heart?
Rabemek DSR is not harmful for the heart.
Rabemek DSR should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rabemek DSR unless your doctor advises you to do so -
Is this Rabemek DSR habit forming or addictive?
No, you will not get addicted to Rabemek DSR.
Interaction between Food and Rabemek DSR
You can take Rabemek DSR with food.
Interaction between Alcohol and Rabemek DSR
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Rabemek DSR.
Yes, Rabemek DSR might lead to low magnesium levels in persons who take it for at least 3 months. Magnesium helps in absorption of vitamin D and calcium, low level of magnesium will affect the absorption of Vit. D and calcium lead to decrease bone density and increases the risk of bone fracture. Low-level magnesium can be managed by taking a dietary supplement which is rich in magnesium.
Rarely Rabemek DSR causes stomach cancer. There has been no direct relationship to establish the fact. However, stomach cancer and other cancers may develop because of recurring acid reflux for a long time for example 7 - 8 years or more. If you feel any symptoms associated with cancer such as consistent low-grade fever, weight loss due to unexplained reasons, and pain in the abdomen, do not hesitate to get it diagnosed by a physician.
Rarely, Rabemek DSR causes hair loss. This is a reversible side effect of Rabemek DSR, the problem goes away after discontinuation of this drug. For partial hair loss, you are advised to use hair tonic and discuss with your doctor about a better treatment option for hair loss.
No, Rabemek DSR doesn't cause high blood pressure. High blood pressure can be managed by losing some amount of weight, doing some kind of physical activity on a daily basis, eating a healthy diet, reducing sodium in the diet, limiting the amount of alcohol and caffeine, quitting smoking, and taking less stress. If your blood pressure doesn't get controlled, your doctor might start you on a hypertensive drug ( amlodipine, telmisartan etc). Please follow the instructions of your doctor completely.
Yes, Rabemek DSR is given in combination with itopride. The combination is used for the management of gastro-esophageal reflux disorder (GERD).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 666-667
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1310-1311